InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
30%
T+90 mean return
-5.6%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by ROTE WILLIAM E., Executive. Director active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 22 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €263k. History available since 11 May 2021. The latest transaction was disclosed on 31 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations22 total
4,920 sharesCommon StockSEC:0001415889-25-012056:0
8,000 sharesCommon StockSEC:0001415889-25-003824:0
21,500 shares0Common StockSEC:0001415889-25-003067:0
2,437 shares@ US$19.4617.3% of flowCommon StockSEC:0001415889-25-002008:0
6,750 shares0Common StockSEC:0001415889-24-023096:0
25,000 shares0Common StockSEC:0001415889-24-002284:0
2,062 shares@ US$8.966.4% of flowCommon StockSEC:0001415889-24-001800:0
3,300 shares0Common StockSEC:0001209191-23-048257:0
825 shares@ US$16.594.7% of flowCommon StockSEC:0001209191-23-029000:0
20,250 shares0Common StockSEC:0001209191-23-006432:0
2,062 shares@ US$21.5015.5% of flowCommon StockSEC:0001209191-23-005036:0
750 shares@ US$21.930.0004% mcap10.6% of flowCommon StockSEC:0001209191-22-028710:0
9,840 shares0Common StockSEC:0001209191-22-006367
9,840 shares0Common StockSEC:0001209191-22-006367:0
1,875 shares@ US$24.980.0010% mcap28.0% of flowCommon StockSEC:0001209191-22-005083:0
1,875 shares@ US$24.980.0010% mcap62.6% of flowCommon StockSEC:0001209191-22-005083
5,000 shares0Common StockSEC:0001209191-22-003050
5,000 shares0Common StockSEC:0001209191-22-003050:0
4,500 shares0Common StockSEC:0001209191-21-052081
4,500 shares0Common StockSEC:0001209191-21-052081:0
1,563 shares@ US$19.1416.7% of flowCommon StockSEC:0001209191-21-032322
1,563 shares@ US$19.140.0006% mcap16.7% of flowCommon StockSEC:0001209191-21-032322:0
22 of 22 declarations
About ROTE WILLIAM E.
William E. Rote is the Senior Vice President of Research and Development at Travere Therapeutics, Inc. He is responsible for leading research initiatives aimed at developing innovative treatments for rare diseases. William E. Rote plays a key role in the company's product development strategy, ensuring that Travere Therapeutics, Inc. remains at the forefront of scientific advancements. His expertise in biopharmaceuticals is crucial for the success of research projects.
